FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DILUENT (diluents)
• insulin lispro (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)